Bayer wins MHRA approval for Kerendia in heart failure
13th April 2026 Uncategorised 0
New authorisation offers additional option for patients with lvef ≥40%

More: Bayer wins MHRA approval for Kerendia in heart failure
Source: News
New authorisation offers additional option for patients with lvef ≥40%

More: Bayer wins MHRA approval for Kerendia in heart failure
Source: News
© 1994 - 2026 B.M. Pharmaceuticals